Federal confidentiality requirements are provided to a patient when _____.
A) Facilities receive a discovery request pursuant to a lawsuit
B) Patients are admitted to a substance abuse treatment program
C) They are discharged from a substance abuse treatment program
D) Payers request records to verify treatment prior to approving payment
Question 2
Which statement is associated with federal regulations regarding the patient identification in a substance abuse program?
A) A substance abuse treatment facility has an unconditional obligation not to identify patients who have been treated.
B) Federal regulations prevent a substance abuse program from disclosing patients who were not treated in their program.
C) General hospitals are prohibited from revealing patient admission status, even when the diagnosis is not substance abuse related.
D) Providers are permitted to release patient identification information related to substance abuse treatment at their office.
Bilateral psoriasis on a patient’s knees.
Apply direct pressure to the patient’s wound.
An open chamber MRI may be more comfortable for the patient, but images may not be as distinct.
Calipers being used to measure body fat on the triceps of a patient.
(a) Chicken pox vesicles. (b) Chicken pox on back of young patient.